SymBio Pharmaceuticals
4582.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 56.25% |
| Cantor Fitzgerald Europe | 7.35% |
| YOSHIDA FUMINORI | 6.35% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| Heights Capital Management, Inc. | 4.18% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 28.30% | -0.17pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 28.47% | -0.81pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 29.28% | -1.14pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 30.42% | -1.10pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 31.52% | -1.37pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 32.89% | -1.74pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 34.63% | -1.08pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 35.71% | -1.30pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 37.01% | -1.06pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 38.07% | -1.02pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.